# 解惑 vs 医安保

The clearest difference is in-app purchases: 医安保 at none against 解惑's 1. 解惑's advantage is device support. On price and iOS requirement there is nothing between them.

Both are free to download. 解惑 sells 1 one-off in-app purchase. 医安保 asks for nothing beyond the download.

## The numbers

| Metric | 解惑 | 医安保 |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[4.9 (62 ratings)](https://appshunter.io/ios/app/and-and-and/id623167344/reviews)** | — |
| Number of ratings | **62** | — |
| Positive reviews | 90.6% of reviews | — |
| In-app purchases | Yes | **No** |
| Ads | No | — |
| Update frequency | Every 9 days | — |
| Monetization | Free with in-app purchases | — |
| Size | 20 MB | 61 MB |
| Requires iOS | 13.0 | **12.0** |
| Devices | **iPhone, iPad, iPod** | — |
| Age rating | 4+ | 17+ |
| Developer | [Xi'an Jinlulai Information Technology Co. Ltd.](https://appshunter.io/developer/1086537482) | [黑龙江蓬希安全科技有限公司](https://appshunter.io/developer/1614196978) |

## What reviewers say

### 解惑

[App page](https://appshunter.io/ios/app/and-and-and/id623167344)

This app offers guidance through traditional Chinese metaphysics like fortune-telling, dream interpretation, and I Ching. It combines ancient wisdom with modern psychology to provide personalized life advice and insights.

**Highlights:** Guanyin Oracle, Daily fortune analysis, Dream interpretation, Wish lantern, Fingerprint fortune telling, Folk divination, I Ching 64 hexagrams

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| 祈福明灯 | $0.99 | one-time |


### 医安保

[App page](https://appshunter.io/ios/app/klgh/id6445837147)

**In-app purchases:** none


## Frequently asked questions

### Is 解惑 free?

解惑 is free to download, with in-app purchases available.

### Is 医安保 free?

医安保 is free to download, with no in-app purchases.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*